Adenocarcinoma of renal cells and Radiation injury

Summary:

Radiation injury is found among people with Adenocarcinoma of renal cells, especially for people who are female, 60+ old.

The study analyzes which people have Radiation injury with Adenocarcinoma of renal cells. It is created by eHealthMe based on reports of 7 people who have Adenocarcinoma of renal cells from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 29, 2023

7 people who have Adenocarcinoma Of Renal Cells and Radiation Injury are studied.


What is Adenocarcinoma of renal cells?

Adenocarcinoma of renal cells (kidney cancer) is found to be associated with 1,698 drugs and 1,126 conditions by eHealthMe.

What is Radiation injury?

Radiation injury (injuries are caused by radiation) is found to be associated with 836 drugs and 421 conditions by eHealthMe.

Number of Radiation injury in Adenocarcinoma of renal cells reports submitted per year:

Would you have Radiation injury when you have Adenocarcinoma of renal cells?

Gender of people who have Adenocarcinoma Of Renal Cells and experienced Radiation Injury *:

  • female: 57.14 %
  • male: 42.86 %

Age of people who have Adenocarcinoma Of Renal Cells and experienced Radiation Injury *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 40 %
  • 60+: 60 %

Common co-existing conditions for these people *:

  1. Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 14.29%

Common drugs taken by these people *:

  1. Sutent: 2 people, 28.57%
  2. Cabometyx: 2 people, 28.57%
  3. Afinitor: 2 people, 28.57%
  4. Spiriva: 1 person, 14.29%
  5. Promethazine Hydrochloride And Codeine Phosphate: 1 person, 14.29%
  6. Proair Hfa: 1 person, 14.29%
  7. Oxycodone And Acetaminophen: 1 person, 14.29%
  8. Mucinex: 1 person, 14.29%
  9. Lidocaine And Prilocaine: 1 person, 14.29%
  10. Lenvima: 1 person, 14.29%

Common symptoms for these people *:

  1. Diarrhea: 3 people, 42.86%
  2. Hair Loss: 3 people, 42.86%
  3. Nausea (feeling of having an urge to vomit): 3 people, 42.86%
  4. Coughing Up Blood: 2 people, 28.57%
  5. Anaemia (lack of blood): 2 people, 28.57%
  6. Swallowing Difficulty: 2 people, 28.57%
  7. Feeling Abnormal: 2 people, 28.57%
  8. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 2 people, 28.57%
  9. Blood Glucose Decreased: 2 people, 28.57%
  10. Itching: 2 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Radiation injury?

Check whether Radiation injury is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Radiation injury:

Common drugs associated with Radiation injury:

All the drugs that are associated with Radiation injury:

All the conditions that are associated with Radiation injury:

How the study uses the data?

The study is based on Radiation injury and Adenocarcinoma of renal cells, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: